{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-336771","form_type":"8-K","ticker":"LNTH","cik":"0001521036","company_name":"Lantheus Holdings, Inc.","filed_at":"2026-08-06T11:45:06+00:00","discovered_at":"2026-08-06T11:50:01.430371+00:00","generated_at":"2026-08-06T11:50:17.041488+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lantheus Q2 revenue $388.2M, EPS $1.11; suspends FY2026 guidance due to pending Curium merger","bullets":["Worldwide revenue $388.2M, up 2.7% YoY; GAAP EPS $1.11 vs $1.12; adjusted EPS $1.55 vs $1.57.","PYLARIFY sales $240.4M (-4.1% YoY); DEFINITY $88.3M (+5.2%); Neuraceq $39.6M.","Operating income $100.2M (+13.9%); adjusted operating income $142.0M (-6.9%).","Company suspends FY2026 guidance and will not hold Q2 call due to pending $8.0B Curium merger (announced Aug 3).","Cash and equivalents $593.3M at June 30, 2026; access to $750M revolver."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-336771","json":"https://secwatch.observer/filing/0001193125-26-336771.json","markdown":"https://secwatch.observer/filing/0001193125-26-336771.md","text":"https://secwatch.observer/filing/0001193125-26-336771.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526336771/0001193125-26-336771-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526336771/lnth-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:50:17.041488+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}